tert-Butyl (3-(3-aminopyridin-4-yl)-5-methylcyclohexyl)carbamate

Catalog No. :
ACMHBP172
CAS No. :
1824388-23-9
Molecular Formula :
C17H27N3O2
Molecular Weight :
305.42

IUPAC Name:tert-butyl (3-(3-aminopyridin-4-yl)-5-methylcyclohexyl)carbamate

tert-Butyl (3-(3-aminopyridin-4-yl)-5-methylcyclohexyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$52.00Login to see priceInquiryInquiry
250mg95%$99.00Login to see priceInquiryInquiry
1g95%$250.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-(3-aminopyridin-4-yl)-5-methylcyclohexyl)carbamate
IUPAC Nametert-butyl (3-(3-aminopyridin-4-yl)-5-methylcyclohexyl)carbamate
MDL No.MFCD24544027
Molecular FormulaC17H27N3O2
Molecular Weight305.42
SMILESO=C(NC1CC(CC(C1)C)C2=C(C=NC=C2)N)OC(C)(C)C
InChI KeyIJNVTEQPYTYYLD-UHFFFAOYSA-N
SynonymTert-Butyl N-[3-(3-Aminopyridin-4-Yl)-5-Methylcyclohexyl]Carbamate;Tert-Butyl N-[3-(3-Aminopyridin-4-Yl)-5-Methylcyclohexyl]Carbamate(WXC04115);Carbamic acid, N-[3-(3-amino-4-pyridinyl)-5-methylcyclohexyl]-, 1,1-dimethylethyl ester;tert-Butyl (3-(3-aminopyridin-4-yl)-5-methylcyclohexyl)carbamate;4-[3-(Boc-amino)-5-methylcyclohexyl]pyridin-3-amine
CAS No.1824388-23-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMHBP172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMHBP172 route product structure diagram
    ACMHBP1721824388-23-9
Inquiry

2. ACMHBP172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMHBP172 route product structure diagram
    ACMHBP1721824388-23-9
Inquiry

Comments (0)